FUJISUE KOICHIRO 藤末昂一郎

… Alternative Names

Fujisue Koichiro 藤末昂一郎

Less

Researcher Number	10779151
Other IDs
Affiliation (Current)	2025: 熊本大学, 病院, 客員助教
Affiliation (based on the past Project Information) *help	2023: 熊本大学, 病院, 客員助教 2022: 熊本大学, 大学院生命科学研究部(医), 助教 2022: 熊本大学, 大学院生命科学研究部循環器内科学, 助教 2019 – 2021: 熊本大学, 病院, 助教 2018: 熊本大学, 医学部附属病院, 助教 2017: 熊本大学, 医学部附属病院, 特任助教
Review Section/Research Field	Principal Investigator Basic Section 53020:Cardiology-related / General pharmacology
Keywords	Principal Investigator 冠動脈疾患 / 免疫チェックポイントタンパク / 免疫チェックポイント分子 / 急性心筋梗塞 / LAG3 / 血管内皮機能 / PD-1 / PD-L1 / 動脈硬化 / 急性冠症候群 … More / リモデリング / NLRP3インフラマソーム / 左室リモデリング / インフラマソーム / 炎症 / 心筋梗塞 / コルヒチン Less

急性心筋梗塞におけるLAG-3の関連性の解明Principal Investigator
- Principal Investigator
  
  藤末昂一郎
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Kumamoto University
The role of PD-1 and PD-L1 in patients with coronary artery diseasePrincipal Investigator
- Principal Investigator
  
  Fujisue Koichiro
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Kumamoto University
Acute anti-inflammatory effects and long-term prognostic benefit of colchicine in acute myocardial infarctionPrincipal Investigator
- Principal Investigator
  
  Fujisue Koichiro
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  General pharmacology
- Research Institution
  Kumamoto University

All 2024 2023 2022 2021 2019 2018

All Journal Article Presentation

[Journal Article] Prognostic Significance of Soluble PD-L1 on Cardiovascular Outcomes in Patients with Coronary Artery Disease2024
- Author(s)
  Miyazaki S, Fujisue K, Yamanaga K, Sueta D, Usuku H, Tabata N, Ishii M, Hanatani S, Hoshiyama T, Kanazawa H, Takashio S, Arima Y, Araki S, Yamamoto E, Matsushita K, Tsujita K.
- Journal Title
  
  Journal of Atherosclerosis and Thrombosis
  
  Volume: 31 Issue: 4 Pages: 355-367
- DOI
  10.5551/jat.64183
- ISSN
  1340-3478, 1880-3873
- Year and Date
  2024-04-01
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08159
[Journal Article] Increased soluble programed cell death-ligand 1 is associated with acute coronary syndrome2022
- Author(s)
  Fujisue Koichiro、Yamamoto Eiichiro、Sueta Daisuke、Takae Masafumi、Nishihara Taiki、Komorita Takashi、Usuku Hiroki、Yamanaga Kenshi、Ito Miwa、Hoshiyama Tadashi、Kanazawa Hisanori、Takashio Seiji、Arima Yuichiro、Araki Satoshi、Soejima Hirofumi、Kaikita Koichi、Matsushita Kenichi、Tsujita Kenichi
- Journal Title
  
  International Journal of Cardiology
  
  Volume: 349 Pages: 1-6
- DOI
  10.1016/j.ijcard.2021.11.060
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08110, KAKENHI-PROJECT-19K17570
[Journal Article] Dose-Dependent Inhibitory Effect of Rosuvastatin in Japanese Patients with Acute Myocardial Infarction on Serum Concentration of Matrix Metalloproteinases–INVITATION Trial–2022
- Author(s)
  Takuhiro Shirakawa, Koichiro Fujisue, et al.
- Journal Title
  
  Journal of Atherosclerosis and Thrombosis
  
  Volume: 29 Issue: 2 Pages: 229-241
- DOI
  10.5551/jat.59477
- NAID
  130008149934
- ISSN
  1340-3478, 1880-3873
- Year and Date
  2022-02-01
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17570
[Presentation] Soluble Programed Cell Death Ligand-1 is Associated with Future Heart Failure Hospitalization in Patients with Atherosclerotic Cardiovascular Disease.2023
- Author(s)
  Atsushi Nozuhara, Koichiro Fujisue, Kenshi Yamanaga, Eiichiro Yamamoto, Koichi Egashira, Takashi Komorita, Daisuke Sueta, Hiroki Usuku, Satoshi Araki, Seiji Takashio, Kenichi Matsushita, Kenichi Tsujita
- Organizer
  第87回日本循環器学会総会・学術集会2023
- Data Source
  KAKENHI-PROJECT-22K08159
[Presentation] Soluble Programed Cell Death Ligand-1 is Associated with Future Heart Failure Hospitalization in Patients with Atherosclerotic Cardiovascular Disease.2023
- Author(s)
  Atsushi Nozuhara, Koichiro Fujisue, Kenshi Yamanaga, Eiichiro Yamamoto, Koichi Egashira, Takashi Komorita, Daisuke Sueta, Hiroki Usuku, Satoshi Araki, Seiji Takashio, Kenichi Matsushita, Kenichi Tsujita
- Organizer
  第87回日本循環器学会総会・学術集会2023
- Data Source
  KAKENHI-PROJECT-19K17570
[Presentation] Soluble programed cell death ligand-1 is associated with future heart failure hospitalization in patients with atherosclerotic cardiovascular disease.2022
- Author(s)
  6.Nozuhara A, Miyazaki S, Fujisue K, Yamanaga K, Yamamoto E, Egashira K, Komorita T, Sueta D, Usuku H, Araki S, Takashio S, Matsushita K, Tsujita K.
- Organizer
  American Heart Association Scientific Sessions 2022
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17570
[Presentation] Prognostic Significance of Soluble Programed Cell Death Ligand-1 on Cardiovascular Outcomes in Patients with Atherosclerotic Cardiovascular Dsease.2021
- Author(s)
  Miyazaki S, Fujisue K, Yamanaga K, Yamamoto E, Egashira K, Komorita T, Sueta D, Usuku H, Araki S, Takasiho S, Matsushita K, Tsujita K.
- Organizer
  American Heart Association Scientific Sessions 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17570
[Presentation] Increased Soluble Programed Cell Death Ligand-1 is Associated with Acute Coronary Syndrome.2021
- Author(s)
  Fujisue K, Miyazaki S, Komorita T, Egashira K, Yamamoto E, Sueta D, Oike F, Usuku H, Takashio S, Araki S, Matsushita K, Tsujita K.
- Organizer
  American Heart Association Scientific Sessions 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17570
[Presentation] Soluble programed cell death ligand-1 is associated with acute coronary syndrome.2019
- Author(s)
  Koichiro Fujisue
- Organizer
  ESC Asia with APSC & AFC, 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17570
[Presentation] Soluble Programed Cell Death Ligand-1 Is Associated with Acute Coronary Syndrome.2019
- Author(s)
  Koichiro Fujisue
- Organizer
  American Heart Association Scientific Sessions 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17570
[Presentation] 心血管領域におけるコルヒチンの動向2018
- Author(s)
  藤末　昂一郎、泉家　康宏、海北　幸一、辻田　賢一
- Organizer
  第14回Cardiovascular Translational Research Conference
- Invited
- Data Source
  KAKENHI-PROJECT-17K17956
[Presentation] 心血管領域におけるコルヒチンの動向2018
- Author(s)
  藤末昂一郎、泉家康宏、海北幸一、辻田賢一
- Organizer
  第14回Cardiovascular Translational Research Conference
- Invited
- Data Source
  KAKENHI-PROJECT-17K17956

1. TSUJITA Kenichi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

FUJISUE KOICHIRO 藤末 昂一郎

Fujisue Koichiro 藤末 昂一郎

Research Projects

Research Products

Co-Researchers

急性心筋梗塞におけるLAG-3の関連性の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The role of PD-1 and PD-L1 in patients with coronary artery diseasePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Acute anti-inflammatory effects and long-term prognostic benefit of colchicine in acute myocardial infarctionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Prognostic Significance of Soluble PD-L1 on Cardiovascular Outcomes in Patients with Coronary Artery Disease2024

Author(s)

Journal Title

DOI

ISSN

Year and Date

Language

Data Source

[Journal Article] Increased soluble programed cell death-ligand 1 is associated with acute coronary syndrome2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dose-Dependent Inhibitory Effect of Rosuvastatin in Japanese Patients with Acute Myocardial Infarction on Serum Concentration of Matrix Metalloproteinases–INVITATION Trial–2022

Author(s)

Journal Title

DOI

NAID

ISSN

Year and Date

Language

Data Source

[Presentation] Soluble Programed Cell Death Ligand-1 is Associated with Future Heart Failure Hospitalization in Patients with Atherosclerotic Cardiovascular Disease.2023

Author(s)

Organizer

Data Source

[Presentation] Soluble Programed Cell Death Ligand-1 is Associated with Future Heart Failure Hospitalization in Patients with Atherosclerotic Cardiovascular Disease.2023

Author(s)

Organizer

Data Source

[Presentation] Soluble programed cell death ligand-1 is associated with future heart failure hospitalization in patients with atherosclerotic cardiovascular disease.2022

Author(s)

Organizer

Data Source

[Presentation] Prognostic Significance of Soluble Programed Cell Death Ligand-1 on Cardiovascular Outcomes in Patients with Atherosclerotic Cardiovascular Dsease.2021

Author(s)

Organizer

Data Source

[Presentation] Increased Soluble Programed Cell Death Ligand-1 is Associated with Acute Coronary Syndrome.2021

Author(s)

Organizer

Data Source

[Presentation] Soluble programed cell death ligand-1 is associated with acute coronary syndrome.2019

Author(s)

Organizer

Data Source

[Presentation] Soluble Programed Cell Death Ligand-1 Is Associated with Acute Coronary Syndrome.2019

Author(s)

Organizer

Data Source

[Presentation] 心血管領域におけるコルヒチンの動向2018

Author(s)

Organizer

Data Source

[Presentation] 心血管領域におけるコルヒチンの動向2018

Author(s)

Organizer

FUJISUE KOICHIRO 藤末昂一郎

Fujisue Koichiro 藤末昂一郎